Artwork

Nội dung được cung cấp bởi A Cure In Sight. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được A Cure In Sight hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.
Player FM - Ứng dụng Podcast
Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !

D2 Track 2 Session 4: Research does NOT equal a cure - WHAT brings a drug to market?

1:02:15
 
Chia sẻ
 

Manage episode 388368422 series 3530258
Nội dung được cung cấp bởi A Cure In Sight. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được A Cure In Sight hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.

In this session, hear from various experts about what it takes to get a drug to market. The bottom line is that research simply does NOT equal a cure. Learn from some of the best in the uveal melanoma pharma world about the process of bringing a treatment or new drug to market.

Experts include Dr. Katz, Chief Medical Officer at TriSalus Life Sciences; Dr. Wade from Aura Bioscienes, Lucinda Innes, a PHD research student investigating uveal melanoma, and research board member Kevin.

Dr. Steven Katz has been the Chief Medical Officer at TriSalus since September 2020 and is Chairman of the Scientific Advisory Board, which includes leadership of TriSalus’ Translational Immunotherapy Laboratory.

Christian Wade, PhD is a medical affairs leader with over 16 years of experience in the pharmaceutical industry. He is currently the Director of Field Medical Affairs at Aura Biosciences, where he is responsible for leading the field medical affairs team for a portfolio of innovative therapies. Dr. Wade is a graduate of the University of San Francisco and holds a PhD in pharmacology from the University of Washington. He is a member of the Medical Affairs Association and the Pharmaceutical Research and Manufacturers of America.

Lucy was born and raised in Seattle and attended Western Washington University, where she earned her degree in biochemistry. In 2021, she pursued her PhD at Weill Cornell Medicine in New York City. During her first year there, she was diagnosed with Ocular Melanoma. This personal challenge inspired her to redirect her research focus towards the disease. Since her diagnosis in the fall of 2022, Lucy has been delving into the interactions between the immune system and ocular melanoma, aiming to improve the future of immunotherapies.

Email questions to contact@acureinsight.org

ANNOUNCEMENTS:

5K SITES ARE OPEN FOR REGISTRATION NEAR YOU! Start your team and bring your community to get involved!

November 11, Los Angeles CA

https://runsignup.com/Race/CA/SantaMonica/LookinForACureLosAngeles

November 19, Phoenix, AZ

https://runsignup.com/Race/AZ/Scottsdale/LookinforaCure5k

December 9, Dallas FTW TX

https://runsignup.com/Race/TX/FortWorth/LookinForACureFortWorth

December 10, Houston, TX

https://runsignup.com/Race/TX/Houston/LookinForACureHouston

January 20, 2024 Orlando FL

https://runsignup.com/Race/FL/Orlando/LookinForACureTampa

January 21, 2024, Miami FL

https://runsignup.com/Race/FL/Miami/LookinForACureMiami

Head to our site to register for a 5K Lookin’ for a Cure near you for the remainder of the year!!
www.lookinforacure.org
Subscribe to the newsletter to stay in the know
Newsletter link

Email contact@acureinsight.org for questions regarding any upcoming events!
*********

Be sure to follow us on Facebook, Twitter, Linked In, or Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM!

*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more!
Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure.
Contribute via PAYPAL OR VENMO or reach out directly to contact@acureinsight.org

  continue reading

165 tập

Artwork
iconChia sẻ
 
Manage episode 388368422 series 3530258
Nội dung được cung cấp bởi A Cure In Sight. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được A Cure In Sight hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.

In this session, hear from various experts about what it takes to get a drug to market. The bottom line is that research simply does NOT equal a cure. Learn from some of the best in the uveal melanoma pharma world about the process of bringing a treatment or new drug to market.

Experts include Dr. Katz, Chief Medical Officer at TriSalus Life Sciences; Dr. Wade from Aura Bioscienes, Lucinda Innes, a PHD research student investigating uveal melanoma, and research board member Kevin.

Dr. Steven Katz has been the Chief Medical Officer at TriSalus since September 2020 and is Chairman of the Scientific Advisory Board, which includes leadership of TriSalus’ Translational Immunotherapy Laboratory.

Christian Wade, PhD is a medical affairs leader with over 16 years of experience in the pharmaceutical industry. He is currently the Director of Field Medical Affairs at Aura Biosciences, where he is responsible for leading the field medical affairs team for a portfolio of innovative therapies. Dr. Wade is a graduate of the University of San Francisco and holds a PhD in pharmacology from the University of Washington. He is a member of the Medical Affairs Association and the Pharmaceutical Research and Manufacturers of America.

Lucy was born and raised in Seattle and attended Western Washington University, where she earned her degree in biochemistry. In 2021, she pursued her PhD at Weill Cornell Medicine in New York City. During her first year there, she was diagnosed with Ocular Melanoma. This personal challenge inspired her to redirect her research focus towards the disease. Since her diagnosis in the fall of 2022, Lucy has been delving into the interactions between the immune system and ocular melanoma, aiming to improve the future of immunotherapies.

Email questions to contact@acureinsight.org

ANNOUNCEMENTS:

5K SITES ARE OPEN FOR REGISTRATION NEAR YOU! Start your team and bring your community to get involved!

November 11, Los Angeles CA

https://runsignup.com/Race/CA/SantaMonica/LookinForACureLosAngeles

November 19, Phoenix, AZ

https://runsignup.com/Race/AZ/Scottsdale/LookinforaCure5k

December 9, Dallas FTW TX

https://runsignup.com/Race/TX/FortWorth/LookinForACureFortWorth

December 10, Houston, TX

https://runsignup.com/Race/TX/Houston/LookinForACureHouston

January 20, 2024 Orlando FL

https://runsignup.com/Race/FL/Orlando/LookinForACureTampa

January 21, 2024, Miami FL

https://runsignup.com/Race/FL/Miami/LookinForACureMiami

Head to our site to register for a 5K Lookin’ for a Cure near you for the remainder of the year!!
www.lookinforacure.org
Subscribe to the newsletter to stay in the know
Newsletter link

Email contact@acureinsight.org for questions regarding any upcoming events!
*********

Be sure to follow us on Facebook, Twitter, Linked In, or Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM!

*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more!
Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure.
Contribute via PAYPAL OR VENMO or reach out directly to contact@acureinsight.org

  continue reading

165 tập

Toate episoadele

×
 
Loading …

Chào mừng bạn đến với Player FM!

Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.

 

Hướng dẫn sử dụng nhanh